Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosisPer Soelberg Sørensen, Massimo Filippi, Steen Lisby et al.|Neurology|2014Cited by 276
Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MSJames Sumowski, Massimo Filippi, Maria A. Rocca et al.|Neurology|2014Cited by 200
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trialDiego Cadavid, Rogier Hintzen, Michelle Mellion et al.|The Lancet Neurology|2019Cited by 185
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndromeClara Matute‐Blanch, Manuel Comabella, Luisa María Villar et al.|Brain|2018Cited by 161
A multicenter assessment of cervical cord atrophy among MS clinical phenotypesMaria A. Rocca, Massimo Filippi, Mark A. Horsfield et al.|Neurology|2011Cited by 137